Clinical Trial Update: TOF Versus SOX in Metastatic Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial comparing the TOF and SOX regimens in metastatic gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• SOX regimen (S-1 and oxaliplatin)
• TOF regimen

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Gastric Cancer | Phase 2, Phase 3 | Status: COMPLETED